• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-氟尿嘧啶与亚叶酸钙24小时持续输注在器官功能障碍患者中的I期及药代动力学研究

Phase I and pharmacokinetic study of 24-hour infusion 5-fluorouracil and leucovorin in patients with organ dysfunction.

作者信息

Fleming G F, Schilsky R L, Schumm L P, Meyerson A, Hong A M, Vogelzang N J, Ratain M J

机构信息

Department of Medicine, University of Chicago Medical Center, IL 60637-1470, USA.

出版信息

Ann Oncol. 2003 Jul;14(7):1142-7. doi: 10.1093/annonc/mdg302.

DOI:10.1093/annonc/mdg302
PMID:12853359
Abstract

BACKGROUND

Patients with hepatic or renal dysfunction are often treated with 5-fluorouracil (5-FU), but there are few data to confirm the safety of this practice.

PATIENTS AND METHODS

Patients with solid tumors were eligible if they were able to fit into one of three organ dysfunction cohorts: I, creatinine >1.5 but < or =3.0 mg/dl and normal bilirubin; II, bilirubin >1.5 but <5.0 mg/dl with normal creatinine; or III, bilirubin > or =5.0 mg/dl with normal creatinine. 5-FU doses were escalated separately within each of the three cohorts. Leucovorin (LV) dosage was fixed at 500 mg/m(2). 5-FU was given as a 24-h infusion at 1000, 1800 or 2600 mg/m(2), and plasma concentrations were measured every 3 h during the first two infusions for each patient.

RESULTS

Sixty-four patients were treated. Toxicities did not appear to be related to organ dysfunction cohort. A weekly dose of of 5-FU 2600 mg/m(2) produced dose-limiting toxicity (DLT) in six of 20 evaluable patients. These DLTs included grade 3 fatigue (n = 3), grade 2 neutropenia precluding weekly dosing (n = 1), grade 3 thrombocytopenia (n = 1) and grade 3 mental status changes (n = 1). There was no relationship between serum bilirubin or serum creatinine and 5-FU clearance.

CONCLUSIONS

Patients with elevated bilirubin may be safely started on a weekly regimen of 5-FU 2600 mg/m(2) with leucovorin 500 mg/m(2) as a 24-h continuous infusion.

摘要

背景

肝功能或肾功能不全的患者常接受5-氟尿嘧啶(5-FU)治疗,但鲜有数据证实这种治疗方法的安全性。

患者与方法

实体瘤患者若符合以下三个器官功能不全队列之一即可入选:队列I,肌酐>1.5但≤3.0mg/dl且胆红素正常;队列II,胆红素>1.5但<5.0mg/dl且肌酐正常;或队列III,胆红素≥5.0mg/dl且肌酐正常。5-FU剂量在三个队列中分别递增。亚叶酸钙(LV)剂量固定为500mg/m²。5-FU以1000、1800或2600mg/m²的剂量进行24小时输注,每位患者在前两次输注期间每3小时测量一次血浆浓度。

结果

64例患者接受了治疗。毒性似乎与器官功能不全队列无关。每周剂量为2600mg/m²的5-FU在20例可评估患者中有6例产生了剂量限制性毒性(DLT)。这些DLT包括3级疲劳(n = 3)、2级中性粒细胞减少导致无法每周给药(n = 1)、3级血小板减少(n = 1)和3级精神状态改变(n = 1)。血清胆红素或血清肌酐与5-FU清除率之间无相关性。

结论

胆红素升高的患者可以安全地开始接受每周一次的5-FU 2600mg/m²联合亚叶酸钙500mg/m²的24小时持续输注方案。

相似文献

1
Phase I and pharmacokinetic study of 24-hour infusion 5-fluorouracil and leucovorin in patients with organ dysfunction.5-氟尿嘧啶与亚叶酸钙24小时持续输注在器官功能障碍患者中的I期及药代动力学研究
Ann Oncol. 2003 Jul;14(7):1142-7. doi: 10.1093/annonc/mdg302.
2
Phase I and pharmacokinetic trial of weekly oral fluorouracil given with eniluracil and low-dose leucovorin to patients with solid tumors.每周口服氟尿嘧啶联合乙磺酰脲和低剂量亚叶酸钙用于实体瘤患者的I期和药代动力学试验。
J Clin Oncol. 2000 Dec 1;18(23):3952-63. doi: 10.1200/JCO.2000.18.23.3952.
3
Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers.Ⅰ期、药代动力学和骨髓药物水平研究:转移性结直肠癌患者每 3 个月接受高剂量氟尿嘧啶和亚叶酸 48 小时输注。
Anticancer Drugs. 2011 Mar;22(3):290-8. doi: 10.1097/CAD.0b013e3283426112.
4
Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.蛋白激酶C-α反义寡核苷酸ISIS 3521联合5-氟尿嘧啶和亚叶酸钙用于晚期癌症患者的I期临床及药代动力学研究。
Clin Cancer Res. 2002 Apr;8(4):1042-8.
5
A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer.一项针对晚期胃癌患者的I期研究,采用每周一次多西他赛、24小时输注高剂量氟尿嘧啶/亚叶酸钙和顺铂的方案。
Oncology. 2002;63(3):239-47. doi: 10.1159/000065471.
6
Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.采用每周24小时输注方案消除顺铂、5-氟尿嘧啶和亚叶酸钙的剂量限制性毒性,用于治疗鼻咽癌患者。
Cancer. 1995 Dec 1;76(11):2186-92. doi: 10.1002/1097-0142(19951201)76:11<2186::aid-cncr2820761103>3.0.co;2-y.
7
Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies.奥沙利铂联合伊立替康及亚叶酸钙调节的5-氟尿嘧啶每两周一次三联方案:晚期胃肠道恶性肿瘤患者的剂量探索性研究
Ann Oncol. 2002 Dec;13(12):1874-81. doi: 10.1093/annonc/mdf307.
8
Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignancies.PN401与氟尿嘧啶用于晚期实体恶性肿瘤患者的I期及药理学研究。
J Clin Oncol. 2000 Jan;18(1):167-77. doi: 10.1200/JCO.2000.18.1.167.
9
Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.每周一次5-氟尿嘧啶联合粒细胞-巨噬细胞集落刺激因子及高剂量亚叶酸钙的I期和药代动力学研究:生长因子作为黏膜保护剂的潜在作用
Cancer Invest. 1999;17(1):1-9.
10
A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours.一项关于伊立替康(CPT-11)短时间静脉输注联合固定剂量5-氟尿嘧啶(5-FU)长时间静脉输注用于晚期实体瘤成年患者的I期剂量探索性研究。
Cancer Chemother Pharmacol. 2005 May;55(5):453-60. doi: 10.1007/s00280-004-0915-x. Epub 2004 Oct 26.

引用本文的文献

1
Plasma clearance of 5-fluorouracil is more influenced by variations in glomerular filtration rate than by uracil concentration.5-氟尿嘧啶的血浆清除率受肾小球滤过率变化的影响大于受尿嘧啶浓度的影响。
Cancer Chemother Pharmacol. 2024 Dec 19;95(1):9. doi: 10.1007/s00280-024-04732-x.
2
A case of an elderly patient with high-grade colorectal cancer in poor general condition who showed near complete response to chemotherapy and achieved long-term survival.一名老年患者,患有高级别结直肠癌,全身状况较差,对化疗表现出近乎完全缓解并实现了长期生存。
Int J Surg Case Rep. 2019;58:186-189. doi: 10.1016/j.ijscr.2019.03.015. Epub 2019 Mar 22.
3
Basket Trials for Intractable Cancer.
难治性癌症的篮式试验
Front Oncol. 2019 Apr 12;9:229. doi: 10.3389/fonc.2019.00229. eCollection 2019.
4
Decreased Disposition of Anticancer Drugs Predominantly Eliminated via the Liver in Patients with Renal Failure.肾功能衰竭患者体内主要经肝脏消除的抗癌药物处置减少。
Curr Drug Metab. 2019;20(5):361-376. doi: 10.2174/1389200220666190402143125.
5
Dosage Adjustments for Chemotherapy and Targeted Therapies in Colorectal and Pancreatic Cancer Patients with Hepatic Impairment.肝功能损害的结直肠癌和胰腺癌患者化疗及靶向治疗的剂量调整
Cureus. 2018 Jun 13;10(6):e2798. doi: 10.7759/cureus.2798.
6
Safe use of capecitabine-cisplatin in metastatic gastric carcinoma with severe liver dysfunction: a case report from Algeria.卡培他滨联合顺铂在重度肝功能不全转移性胃癌中的安全应用:来自阿尔及利亚的一例病例报告
Electron Physician. 2017 Aug 25;9(8):4942-4945. doi: 10.19082/4942. eCollection 2017 Aug.
7
Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic function.肝功能异常的肝胆癌患者的化疗
J Gastrointest Oncol. 2017 Apr;8(2):314-323. doi: 10.21037/jgo.2016.09.17.
8
Hepatotoxicity Secondary to Chemotherapy.化疗相关肝毒性。
J Clin Transl Hepatol. 2014 Jun;2(2):95-102. doi: 10.14218/JCTH.2014.00011. Epub 2014 Jun 15.
9
Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer.转移性结直肠癌患者严重肝功能不全时的化疗
Case Rep Oncol Med. 2015;2015:420159. doi: 10.1155/2015/420159. Epub 2015 May 21.
10
Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusion.24小时恒速输注期间血浆5-氟尿嘧啶浓度的昼夜变化。
BMC Cancer. 2015 Feb 18;15:69. doi: 10.1186/s12885-015-1075-6.